Global Personalized Cell Therapeutic Market Growth 2022-2028
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Personalized Cell Therapeutic Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Personalized Cell Therapeutic by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Personalized Cell Therapeutic by Country/Region, 2017, 2022 & 2028
- 2.2 Personalized Cell Therapeutic Segment by Type
- 2.2.1 Embryonic Stem Cells
- 2.2.2 Adult Stem Cell
- 2.2.3 Induced Pluripotent Cells
- 2.2.4 Other
- 2.3 Personalized Cell Therapeutic Sales by Type
- 2.3.1 Global Personalized Cell Therapeutic Sales Market Share by Type (2017-2022)
- 2.3.2 Global Personalized Cell Therapeutic Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Personalized Cell Therapeutic Sale Price by Type (2017-2022)
- 2.4 Personalized Cell Therapeutic Segment by Application
- 2.4.1 Cardiovascular Diseases
- 2.4.2 Neurological Disorders
- 2.4.3 Diabetes
- 2.4.4 Oncology
- 2.4.5 Other
- 2.5 Personalized Cell Therapeutic Sales by Application
- 2.5.1 Global Personalized Cell Therapeutic Sale Market Share by Application (2017-2022)
- 2.5.2 Global Personalized Cell Therapeutic Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Personalized Cell Therapeutic Sale Price by Application (2017-2022)
3 Global Personalized Cell Therapeutic by Company
- 3.1 Global Personalized Cell Therapeutic Breakdown Data by Company
- 3.1.1 Global Personalized Cell Therapeutic Annual Sales by Company (2020-2022)
- 3.1.2 Global Personalized Cell Therapeutic Sales Market Share by Company (2020-2022)
- 3.2 Global Personalized Cell Therapeutic Annual Revenue by Company (2020-2022)
- 3.2.1 Global Personalized Cell Therapeutic Revenue by Company (2020-2022)
- 3.2.2 Global Personalized Cell Therapeutic Revenue Market Share by Company (2020-2022)
- 3.3 Global Personalized Cell Therapeutic Sale Price by Company
- 3.4 Key Manufacturers Personalized Cell Therapeutic Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Personalized Cell Therapeutic Product Location Distribution
- 3.4.2 Players Personalized Cell Therapeutic Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Personalized Cell Therapeutic by Geographic Region
- 4.1 World Historic Personalized Cell Therapeutic Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Personalized Cell Therapeutic Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Personalized Cell Therapeutic Annual Revenue by Geographic Region
- 4.2 World Historic Personalized Cell Therapeutic Market Size by Country/Region (2017-2022)
- 4.2.1 Global Personalized Cell Therapeutic Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Personalized Cell Therapeutic Annual Revenue by Country/Region
- 4.3 Americas Personalized Cell Therapeutic Sales Growth
- 4.4 APAC Personalized Cell Therapeutic Sales Growth
- 4.5 Europe Personalized Cell Therapeutic Sales Growth
- 4.6 Middle East & Africa Personalized Cell Therapeutic Sales Growth
5 Americas
- 5.1 Americas Personalized Cell Therapeutic Sales by Country
- 5.1.1 Americas Personalized Cell Therapeutic Sales by Country (2017-2022)
- 5.1.2 Americas Personalized Cell Therapeutic Revenue by Country (2017-2022)
- 5.2 Americas Personalized Cell Therapeutic Sales by Type
- 5.3 Americas Personalized Cell Therapeutic Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Personalized Cell Therapeutic Sales by Region
- 6.1.1 APAC Personalized Cell Therapeutic Sales by Region (2017-2022)
- 6.1.2 APAC Personalized Cell Therapeutic Revenue by Region (2017-2022)
- 6.2 APAC Personalized Cell Therapeutic Sales by Type
- 6.3 APAC Personalized Cell Therapeutic Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Personalized Cell Therapeutic by Country
- 7.1.1 Europe Personalized Cell Therapeutic Sales by Country (2017-2022)
- 7.1.2 Europe Personalized Cell Therapeutic Revenue by Country (2017-2022)
- 7.2 Europe Personalized Cell Therapeutic Sales by Type
- 7.3 Europe Personalized Cell Therapeutic Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Personalized Cell Therapeutic by Country
- 8.1.1 Middle East & Africa Personalized Cell Therapeutic Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Personalized Cell Therapeutic Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Personalized Cell Therapeutic Sales by Type
- 8.3 Middle East & Africa Personalized Cell Therapeutic Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Personalized Cell Therapeutic
- 10.3 Manufacturing Process Analysis of Personalized Cell Therapeutic
- 10.4 Industry Chain Structure of Personalized Cell Therapeutic
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Personalized Cell Therapeutic Distributors
- 11.3 Personalized Cell Therapeutic Customer
12 World Forecast Review for Personalized Cell Therapeutic by Geographic Region
- 12.1 Global Personalized Cell Therapeutic Market Size Forecast by Region
- 12.1.1 Global Personalized Cell Therapeutic Forecast by Region (2023-2028)
- 12.1.2 Global Personalized Cell Therapeutic Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Personalized Cell Therapeutic Forecast by Type
- 12.7 Global Personalized Cell Therapeutic Forecast by Application
13 Key Players Analysis
- 13.1 AbbVie Inc
- 13.1.1 AbbVie Inc Company Information
- 13.1.2 AbbVie Inc Personalized Cell Therapeutic Product Offered
- 13.1.3 AbbVie Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 AbbVie Inc Main Business Overview
- 13.1.5 AbbVie Inc Latest Developments
- 13.2 Bausch Health Companies Inc
- 13.2.1 Bausch Health Companies Inc Company Information
- 13.2.2 Bausch Health Companies Inc Personalized Cell Therapeutic Product Offered
- 13.2.3 Bausch Health Companies Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Bausch Health Companies Inc Main Business Overview
- 13.2.5 Bausch Health Companies Inc Latest Developments
- 13.3 Teva Pharmaceutical Industries Ltd
- 13.3.1 Teva Pharmaceutical Industries Ltd Company Information
- 13.3.2 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product Offered
- 13.3.3 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
- 13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
- 13.4 Cipla
- 13.4.1 Cipla Company Information
- 13.4.2 Cipla Personalized Cell Therapeutic Product Offered
- 13.4.3 Cipla Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Cipla Main Business Overview
- 13.4.5 Cipla Latest Developments
- 13.5 Lupin
- 13.5.1 Lupin Company Information
- 13.5.2 Lupin Personalized Cell Therapeutic Product Offered
- 13.5.3 Lupin Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Lupin Main Business Overview
- 13.5.5 Lupin Latest Developments
- 13.6 Sun Pharmaceuticals Industries Ltd
- 13.6.1 Sun Pharmaceuticals Industries Ltd Company Information
- 13.6.2 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product Offered
- 13.6.3 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Sun Pharmaceuticals Industries Ltd Main Business Overview
- 13.6.5 Sun Pharmaceuticals Industries Ltd Latest Developments
- 13.7 Hikma Pharmaceuticals PLC
- 13.7.1 Hikma Pharmaceuticals PLC Company Information
- 13.7.2 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product Offered
- 13.7.3 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Hikma Pharmaceuticals PLC Main Business Overview
- 13.7.5 Hikma Pharmaceuticals PLC Latest Developments
- 13.8 AstraZeneca
- 13.8.1 AstraZeneca Company Information
- 13.8.2 AstraZeneca Personalized Cell Therapeutic Product Offered
- 13.8.3 AstraZeneca Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 AstraZeneca Main Business Overview
- 13.8.5 AstraZeneca Latest Developments
- 13.9 GSK Plc
- 13.9.1 GSK Plc Company Information
- 13.9.2 GSK Plc Personalized Cell Therapeutic Product Offered
- 13.9.3 GSK Plc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 GSK Plc Main Business Overview
- 13.9.5 GSK Plc Latest Developments
- 13.10 Pfizer Inc
- 13.10.1 Pfizer Inc Company Information
- 13.10.2 Pfizer Inc Personalized Cell Therapeutic Product Offered
- 13.10.3 Pfizer Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Pfizer Inc Main Business Overview
- 13.10.5 Pfizer Inc Latest Developments
- 13.11 Amneal Pharmaceuticals LLC
- 13.11.1 Amneal Pharmaceuticals LLC Company Information
- 13.11.2 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product Offered
- 13.11.3 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 Amneal Pharmaceuticals LLC Main Business Overview
- 13.11.5 Amneal Pharmaceuticals LLC Latest Developments
- 13.12 Alvogen
- 13.12.1 Alvogen Company Information
- 13.12.2 Alvogen Personalized Cell Therapeutic Product Offered
- 13.12.3 Alvogen Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.12.4 Alvogen Main Business Overview
- 13.12.5 Alvogen Latest Developments
- 13.13 F. Hoffmann-La Roche Ltd
- 13.13.1 F. Hoffmann-La Roche Ltd Company Information
- 13.13.2 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product Offered
- 13.13.3 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.13.4 F. Hoffmann-La Roche Ltd Main Business Overview
- 13.13.5 F. Hoffmann-La Roche Ltd Latest Developments
- 13.14 Amgen Inc
- 13.14.1 Amgen Inc Company Information
- 13.14.2 Amgen Inc Personalized Cell Therapeutic Product Offered
- 13.14.3 Amgen Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.14.4 Amgen Inc Main Business Overview
- 13.14.5 Amgen Inc Latest Developments
- 13.15 Jazz Pharmaceuticals, Inc
- 13.15.1 Jazz Pharmaceuticals, Inc Company Information
- 13.15.2 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product Offered
- 13.15.3 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.15.4 Jazz Pharmaceuticals, Inc Main Business Overview
- 13.15.5 Jazz Pharmaceuticals, Inc Latest Developments
- 13.16 Amicus Therapeutics, Inc
- 13.16.1 Amicus Therapeutics, Inc Company Information
- 13.16.2 Amicus Therapeutics, Inc Personalized Cell Therapeutic Product Offered
- 13.16.3 Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.16.4 Amicus Therapeutics, Inc Main Business Overview
- 13.16.5 Amicus Therapeutics, Inc Latest Developments
- 13.17 MeiraGTx Limited
- 13.17.1 MeiraGTx Limited Company Information
- 13.17.2 MeiraGTx Limited Personalized Cell Therapeutic Product Offered
- 13.17.3 MeiraGTx Limited Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.17.4 MeiraGTx Limited Main Business Overview
- 13.17.5 MeiraGTx Limited Latest Developments
- 13.18 Rocket Pharmaceuticals, Inc
- 13.18.1 Rocket Pharmaceuticals, Inc Company Information
- 13.18.2 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product Offered
- 13.18.3 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.18.4 Rocket Pharmaceuticals, Inc Main Business Overview
- 13.18.5 Rocket Pharmaceuticals, Inc Latest Developments
- 13.19 Gilead Sciences, Inc
- 13.19.1 Gilead Sciences, Inc Company Information
- 13.19.2 Gilead Sciences, Inc Personalized Cell Therapeutic Product Offered
- 13.19.3 Gilead Sciences, Inc Personalized Cell Therapeutic Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.19.4 Gilead Sciences, Inc Main Business Overview
- 13.19.5 Gilead Sciences, Inc Latest Developments
14 Research Findings and Conclusion
Personalized cells are undifferentiated stem cells that can be divided to generate offspring cells designated as specialized or personalized stem cells. Specialized treatment of numerous chronic diseases such as autoimmune and cancer through vaccinating living cells into the body of patients to boost the personalized cell therapy market. As there are multiple types of living cells such as immature and mature living cell, blood and bone marrow cell and embryonic stem cells that are mainly utilized in personalized cell therapy.
The global market for Personalized Cell Therapeutic is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Personalized Cell Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Personalized Cell Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Personalized Cell Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Personalized Cell Therapeutic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Personalized Cell Therapeutic players cover AbbVie Inc, Bausch Health Companies Inc, Teva Pharmaceutical Industries Ltd, Cipla and Lupin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Personalized Cell Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Personalized Cell Therapeutic market, with both quantitative and qualitative data, to help readers understand how the Personalized Cell Therapeutic market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Personalized Cell Therapeutic market and forecasts the market size by Type (Embryonic Stem Cells, Adult Stem Cell and Induced Pluripotent Cells), by Application (Cardiovascular Diseases, Neurological Disorders, Diabetes and Oncology), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Embryonic Stem Cells
Adult Stem Cell
Induced Pluripotent Cells
Other
Segmentation by application
Cardiovascular Diseases
Neurological Disorders
Diabetes
Oncology
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
AbbVie Inc
Bausch Health Companies Inc
Teva Pharmaceutical Industries Ltd
Cipla
Lupin
Sun Pharmaceuticals Industries Ltd
Hikma Pharmaceuticals PLC
AstraZeneca
GSK Plc
Pfizer Inc
Amneal Pharmaceuticals LLC
Alvogen
F. Hoffmann-La Roche Ltd
Amgen Inc
Jazz Pharmaceuticals, Inc
Amicus Therapeutics, Inc
MeiraGTx Limited
Rocket Pharmaceuticals, Inc
Gilead Sciences, Inc
Chapter Introduction
Chapter 1: Scope of Personalized Cell Therapeutic, Research Methodology, etc.
Chapter 2: Executive Summary, global Personalized Cell Therapeutic market size (sales and revenue) and CAGR, Personalized Cell Therapeutic market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Personalized Cell Therapeutic sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Personalized Cell Therapeutic sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Personalized Cell Therapeutic market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including AbbVie Inc, Bausch Health Companies Inc, Teva Pharmaceutical Industries Ltd, Cipla, Lupin, Sun Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, AstraZeneca and GSK Plc, etc.
Chapter 14: Research Findings and Conclusion